BioMed Research International
Volume 2013 (2013), Article ID 258141, 4 pages
http://dx.doi.org/10.1155/2013/258141
The Role of Morphine in Animal Models of Human Cancer: Does Morphine Promote or Inhibit the Tumor Growth?
1Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione G. Pascale,” IRCCS, Via Mariano Semmola, 80131 Naples, Italy
2Istituto di Endocrinologia e Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, Dipartimento di Biologia e Patologia Cellulare e Molecolare “L. Califano,” Università degli Studi di Napoli “Federico II,” Via Pansini 5, 80131 Napoli, Italy
Received 16 July 2013; Accepted 29 July 2013
Academic Editor: Monica Fedele
Copyright © 2013 Sabrina Bimonte et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- J. N. Lickiss, “Approaching cancer pain relief,” European Journal of Pain, vol. 5, pp. 5–14, 2001. View at Publisher · View at Google Scholar · View at Scopus
- R. Schmitz, “Friedrich Wilhelm Sertürner and the discovery of morphine,” Pharmacy in history, vol. 27, no. 2, pp. 61–74, 1985. View at Google Scholar · View at Scopus
- G. W. Pasternak, “Pharmacological mechanisms of opioid analgesics,” Clinical Neuropharmacology, vol. 16, no. 1, pp. 1–18, 1993. View at Google Scholar · View at Scopus
- B. L. Kieffer and C. Gavériaux-Ruff, “Exploring the opioid system by gene knockout,” Progress in Neurobiology, vol. 66, no. 5, pp. 285–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
- P. W. Mantyh, “Cancer pain and its impact on diagnosis, survival and quality of life,” Nature Reviews Neuroscience, vol. 7, no. 10, pp. 797–809, 2006. View at Publisher · View at Google Scholar · View at Scopus
- N. Sueoka, E. Sueoka, S. Okabe, and H. Fujiki, “Anti-cancer effects of morphine through inhibition of tumour necrosis factor-α release and mRNA expression,” Carcinogenesis, vol. 17, no. 11, pp. 2337–2341, 1996. View at Google Scholar · View at Scopus
- R. Maneckjee and J. D. Minna, “Opioids induce while nicotine suppresses apoptosis in human lung cancer cells,” Cell Growth and Differentiation, vol. 5, no. 10, pp. 1033–1040, 1994. View at Google Scholar · View at Scopus
- A. Pasi, B. Qu, R. Steiner, H.-J. Senn, W. Bar, and F. S. Messiha, “Angiogenesis: modulation with opioids,” General Pharmacology, vol. 22, no. 6, pp. 1077–1079, 1991. View at Publisher · View at Google Scholar · View at Scopus
- A. Hatzoglou, E. Bakogeorgou, E. Papakonstanti, C. Stournaras, D. S. Emmanouel, and E. Castanas, “Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth,” Journal of Cellular Biochemistry, vol. 63, no. 4, pp. 410–421, 1996. View at Google Scholar
- A. Hatzoglou, L. Ouafik, E. Bakogeorgou, K. Thermos, and E. Castanas, “Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth,” Cancer Research, vol. 55, no. 23, pp. 5632–5636, 1995. View at Google Scholar · View at Scopus
- R. Maneckjee, R. Biswas, and B. K. Vonderhaar, “Binding of opioids to human MCF-7 breast cancer cells and their effects on growth,” Cancer Research, vol. 50, no. 8, pp. 2234–2238, 1990. View at Google Scholar · View at Scopus
- M. Kampa, E. Bakogeorgou, A. Hatzoglou, A. Damianaki, P.-M. Martin, and E. Castanas, “Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors,” European Journal of Pharmacology, vol. 335, no. 2-3, pp. 255–265, 1997. View at Publisher · View at Google Scholar · View at Scopus
- I. Tegeder, S. Grösch, A. Schmidtko et al., “G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation,” Cancer Research, vol. 63, no. 8, pp. 1846–1852, 2003. View at Google Scholar · View at Scopus
- M. P. Yeager and T. A. Colacchio, “Effect of morphine on growth of metastatic colon cancer in vivo,” Archives of Surgery, vol. 126, no. 4, pp. 454–456, 1991. View at Google Scholar · View at Scopus
- T. Sasamura, S. Nakamura, Y. Iida et al., “Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation,” European Journal of Pharmacology, vol. 441, no. 3, pp. 185–191, 2002. View at Publisher · View at Google Scholar · View at Scopus
- Y. Harimaya, K. Koizumi, T. Andoh, H. Nojima, Y. Kuraishi, and I. Saiki, “Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells,” Cancer Letters, vol. 187, no. 1-2, pp. 121–127, 2002. View at Publisher · View at Google Scholar · View at Scopus
- R. H. Simon and T. E. Arbo, “Morphine increases metastatic tumor growth,” Brain Research Bulletin, vol. 16, no. 3, pp. 363–367, 1986. View at Google Scholar · View at Scopus
- J. W. Lewis, Y. Shavit, and G. W. Terman, “Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth,” Peptides, vol. 4, no. 5, pp. 635–638, 1983. View at Publisher · View at Google Scholar · View at Scopus
- M. G. Sergeeva, Z. V. Grishina, and S. D. Varfolomeyev, “Morphine effect on proliferation of normal and tumor cells of immune origin,” Immunology Letters, vol. 36, no. 2, pp. 215–218, 1993. View at Publisher · View at Google Scholar · View at Scopus
- K. Gupta, S. Kshirsagar, L. Chang et al., “Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth,” Cancer Research, vol. 62, no. 15, pp. 4491–4498, 2002. View at Google Scholar · View at Scopus
- M. Farooqui, Y. Li, T. Rogers et al., “COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia,” British Journal of Cancer, vol. 97, no. 11, pp. 1523–1531, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. Ishikawa, K. Tanno, A. Kamo, Y. Takayanagi, and K.-I. Sasaki, “Enhancement of tumor growth by morphine and its possible mechanism in mice,” Biological and Pharmaceutical Bulletin, vol. 16, no. 8, pp. 762–766, 1993. View at Google Scholar · View at Scopus
- J. Zong and G. M. Pollack, “Morphine antinociception is enhanced in mdr1a gene-deficient mice,” Pharmaceutical Research, vol. 17, no. 6, pp. 749–753, 2000. View at Publisher · View at Google Scholar · View at Scopus
- M. Iglesias, M. F. Segura, J. X. Comella, and G. Olmos, “μ-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase,” Neuropharmacology, vol. 44, no. 4, pp. 482–492, 2003. View at Publisher · View at Google Scholar · View at Scopus
- K. Gach, J. Szemraj, J. Fichna, M. Piestrzeniewicz, D. S. Delbro, and A. Janecka, “The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line,” Chemical Biology and Drug Design, vol. 74, no. 4, pp. 390–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
- P. A. Singleton and J. Moss, “Effect of perioperative opioids on cancer recurrence: a hypothesis,” Future Oncology, vol. 6, no. 8, pp. 1237–1242, 2010. View at Publisher · View at Google Scholar · View at Scopus
- C. Chen, M. Farooqui, and K. Gupta, “Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells,” Current Neurovascular Research, vol. 3, no. 3, pp. 171–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
- D. R. Green and J. C. Reed, “Mitochondria and apoptosis,” Science, vol. 281, no. 5381, pp. 1309–1312, 1998. View at Google Scholar · View at Scopus
- A. Ashkenazi and V. M. Dixit, “Apoptosis control by death and decoy receptors,” Current Opinion in Cell Biology, vol. 11, no. 2, pp. 255–260, 1999. View at Publisher · View at Google Scholar · View at Scopus
- D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Publisher · View at Google Scholar · View at Scopus
- M. O. Hengartner, “The biochemistry of apoptosis,” Nature, vol. 407, no. 6805, pp. 770–776, 2000. View at Publisher · View at Google Scholar · View at Scopus
- P.-N. Hsiao, M.-C. Chang, W.-F. Cheng et al., “Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways,” Toxicology, vol. 256, no. 1-2, pp. 83–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
- A. A. Kapasi, S. A. Coscia, M. P. Pandya, and P. C. Singhal, “Morphine modulates HIV-1 gp160-induced murine macrophage and human monocyte apoptosis by disparate ways,” Journal of Neuroimmunology, vol. 148, no. 1-2, pp. 86–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
- X. Lin, Q. Li, Y.-J. Wang et al., “Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor κB transcriptional activation in neuroblastoma SH-SY5Y cells,” Biochemical Journal, vol. 406, no. 2, pp. 215–221, 2007. View at Publisher · View at Google Scholar · View at Scopus
- R. Arerangaiah, N. Chalasani, A. M. Udager et al., “Opioids induce renal abnormalities in tumor-bearing mice,” Nephron—Experimental Nephrology, vol. 105, no. 3, pp. e80–e89, 2007. View at Publisher · View at Google Scholar · View at Scopus
- D. Salvemini, T. P. Misko, J. L. Masferrer, K. Seibert, M. G. Currie, and P. Needleman, “Nitric oxide activates cyclooxygenase enzymes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 15, pp. 7240–7244, 1993. View at Google Scholar · View at Scopus
- E. Nédélec, A. Abid, C. Cipolletta et al., “Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism,” Biochemical Pharmacology, vol. 61, no. 8, pp. 965–978, 2001. View at Publisher · View at Google Scholar · View at Scopus
- M. Farooqui, Z. H. Geng, E. J. Stephenson, N. Zaveri, D. Yee, and K. Gupta, “Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells,” Molecular Cancer Therapeutics, vol. 5, no. 3, pp. 611–620, 2006. View at Publisher · View at Google Scholar · View at Scopus
- D. Salvemini, K. Seibert, J. L. Masferrer, T. P. Misko, M. G. Currie, and P. Needleman, “Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation,” Journal of Clinical Investigation, vol. 93, no. 5, pp. 1940–1947, 1994. View at Google Scholar · View at Scopus
- R. J. Griffin, B. W. Williams, R. Wild, J. M. Cherrington, H. Park, and C. W. Song, “Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response,” Cancer Research, vol. 62, no. 6, pp. 1702–1706, 2002. View at Google Scholar · View at Scopus
- K. M. Leahy, R. L. Ornberg, Y. Wang, B. S. Zweifel, A. T. Koki, and J. L. Masferrer, “Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo,” Cancer Research, vol. 62, no. 3, pp. 625–631, 2002. View at Google Scholar · View at Scopus
- S. H. Chang, C. H. Liu, R. Conway et al., “Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 2, pp. 591–596, 2004. View at Google Scholar
- C.-F. Lam, Y.-C. Liu, F.-L. Tseng et al., “High-dose morphine impairs vascular endothelial function by increased production of superoxide anions,” Anesthesiology, vol. 106, no. 3, pp. 532–537, 2007. View at Publisher · View at Google Scholar · View at Scopus
- J. Blebea, J. E. Mazo, T. K. Kihara et al., “Opioid growth factor modulates angiogenesis,” Journal of Vascular Surgery, vol. 32, no. 2, pp. 364–373, 2000. View at Publisher · View at Google Scholar · View at Scopus
- C.-F. Lam, P.-J. Chang, Y.-S. Huang et al., “Prolonged use of high-dose morphine impairs angiogenesis and mobilization of endothelial progenitor cells in mice,” Anesthesia and Analgesia, vol. 107, no. 2, pp. 686–692, 2008. View at Publisher · View at Google Scholar · View at Scopus
- J. L. Martin, R. Charboneau, R. A. Barke, and S. Roy, “Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing,” Cellular Immunology, vol. 265, no. 2, pp. 139–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
- S. Roy, S. Balasubramanian, J. Wang, Y. Chandrashekhar, R. Charboneau, and R. Barke, “Morphine inhibits VEGF expression in myocardial ischemia,” Surgery, vol. 134, no. 2, pp. 336–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
- L. Koodie, S. Ramakrishnan, and S. Roy, “Morphine suppresses tumor angiogenesis through a HIF-1α/p38MAPK pathway,” American Journal of Pathology, vol. 177, no. 2, pp. 984–997, 2010. View at Publisher · View at Google Scholar · View at Scopus
- N. Faramarzi, A. Abbasi, S. M. Tavangar, M. Mazouchi, and A. R. Dehpour, “Opioid receptor antagonist promotes angiogenesis in bile duct ligated rats,” Journal of Gastroenterology and Hepatology, vol. 24, no. 7, pp. 1226–1229, 2009. View at Publisher · View at Google Scholar · View at Scopus
- R. L. Shapiro, J. G. Duquette, D. F. Roses et al., “Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals,” Cancer Research, vol. 56, no. 15, pp. 3597–3604, 1996. View at Google Scholar · View at Scopus
- J. A. Engbring and H. K. Kleinman, “The basement membrane matrix in malignancy,” Journal of Pathology, vol. 200, no. 4, pp. 465–470, 2003. View at Publisher · View at Google Scholar · View at Scopus
- M. S. Widel and M. Widel, “Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer,” Postępy Higieny i Medycyny Doświadczalnej, vol. 60, pp. 453–470, 2006. View at Google Scholar
- C. C. Lynch and L. M. Matrisian, “Matrix metalloproteinases in tumor-host cell communication,” Differentiation, vol. 70, no. 9-10, pp. 561–573, 2002. View at Publisher · View at Google Scholar · View at Scopus
- K. Gach, J. Szemraj, A. Wyrȩbska, and A. Janecka, “The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line,” Molecular Biology Reports, vol. 38, no. 2, pp. 1231–1236, 2011. View at Publisher · View at Google Scholar · View at Scopus
- G. Nylund, A. Pettersson, C. Bengtsson, A. Khorram-Manesh, S. Nordgren, and D. S. Delbro, “Functional expression of μ-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon,” Digestive Diseases and Sciences, vol. 53, no. 2, pp. 461–466, 2008. View at Publisher · View at Google Scholar · View at Scopus